Skip to main content
Top
Published in: BMC Urology 1/2014

Open Access 01-12-2014 | Research article

Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy

Authors: Kelvin A Moses, Ling Y Chen, Daniel D Sjoberg, Melanie Bernstein, Karim A Touijer

Published in: BMC Urology | Issue 1/2014

Login to get access

Abstract

Background

Black men with prostate cancer are diagnosed at a younger age, present with more aggressive disease, and experience higher mortality. We sought to assess pathological features and biochemical recurrence (BCR) in young men undergoing radical prostatectomy (RP) to determine if there is a difference between black and white men closer to the time of disease initiation.

Methods

We identified 551 white and 99 black men at a tertiary cancer center who underwent RP at ≤50 years of age. Baseline and pathological features were compared between the two groups. Cox proportional hazards models were utilized to examine the association of race and BCR, and Kaplan-Meier curves were generated to determine biochemical recurrence-free survival (bRFS).

Results

There were no differences in median age at surgery, biopsy Gleason score, or comorbidity. Black men had higher preoperative PSA (6.1 ng/ml vs 4.7 ng/ml, p = 0.004), but a greater percentage were cT1c (78% vs 63%), compared to white men. On multivariate analysis, black men demonstrated significantly lower odds of non-organ confined disease (OR 0.39; 95% CI: 0.18, 0.81; p = 0.01) and extracapsular extension (ECE) (OR 0.38; 95% CI: 0.18, 0.81, p = 0.01), and had no difference in Gleason score upgrading and seminal vesicle invasion compared to white men. There was no significant difference in bRFS in men with organ-confined disease; however, among men with locally advanced disease black men trended towards greater BCR (p = 0.052). Black men had 2-year bRFS of 56% vs 75% in white men.

Conclusions

In this single institution study, there does not appear to be a racial disparity in outcomes among younger men who receive RP for prostate cancer. Black and white men in our cohort demonstrate similar bRFS with pathologically confirmed organ-confined disease. There may be greater risk of BCR among black men locally advanced disease compared to white men, suggesting that locally advanced disease is biologically more aggressive in black men.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011, 61 (4): 212-236. 10.3322/caac.20121.CrossRefPubMed Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011, 61 (4): 212-236. 10.3322/caac.20121.CrossRefPubMed
2.
go back to reference Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ: Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol. 1998, 160 (2): 437-442. 10.1016/S0022-5347(01)62919-7.CrossRefPubMed Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ: Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol. 1998, 160 (2): 437-442. 10.1016/S0022-5347(01)62919-7.CrossRefPubMed
3.
go back to reference Parker PM, Rice KR, Sterbis JR, Chen Y, Cullen J, McLeod DG, Brassell SA: Prostate cancer in men less than the age of 50: a comparison of race and outcomes. Urology. 2011, 78 (1): 110-115. 10.1016/j.urology.2010.12.046.CrossRefPubMed Parker PM, Rice KR, Sterbis JR, Chen Y, Cullen J, McLeod DG, Brassell SA: Prostate cancer in men less than the age of 50: a comparison of race and outcomes. Urology. 2011, 78 (1): 110-115. 10.1016/j.urology.2010.12.046.CrossRefPubMed
4.
go back to reference Bigler SA, Pound CR, Zhou X: A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer. 2011, 2011: 239460-CrossRefPubMedPubMedCentral Bigler SA, Pound CR, Zhou X: A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer. 2011, 2011: 239460-CrossRefPubMedPubMedCentral
5.
go back to reference Eastham JA, Kattan MW: Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol. 2000, 163 (1): 143-145. 10.1016/S0022-5347(05)67990-6.CrossRefPubMed Eastham JA, Kattan MW: Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol. 2000, 163 (1): 143-145. 10.1016/S0022-5347(05)67990-6.CrossRefPubMed
6.
go back to reference Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA: Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010, 28 (6): 1069-1074. 10.1200/JCO.2009.26.2469.CrossRefPubMedPubMedCentral Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA: Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010, 28 (6): 1069-1074. 10.1200/JCO.2009.26.2469.CrossRefPubMedPubMedCentral
7.
go back to reference Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL: Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med. 2003, 18 (10): 845-853. 10.1046/j.1525-1497.2003.21105.x.CrossRefPubMedPubMedCentral Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL: Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med. 2003, 18 (10): 845-853. 10.1046/j.1525-1497.2003.21105.x.CrossRefPubMedPubMedCentral
8.
go back to reference Schapira MM, McAuliffe TL, Nattinger AB: Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care. 1995, 33 (11): 1079-1088. 10.1097/00005650-199511000-00002.CrossRefPubMed Schapira MM, McAuliffe TL, Nattinger AB: Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care. 1995, 33 (11): 1079-1088. 10.1097/00005650-199511000-00002.CrossRefPubMed
9.
go back to reference Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF: Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004, 64 (6): 1171-1176. 10.1016/j.urology.2004.07.037.CrossRefPubMed Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF: Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004, 64 (6): 1171-1176. 10.1016/j.urology.2004.07.037.CrossRefPubMed
10.
go back to reference Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW: Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006, 106 (9): 1865-1874. 10.1002/cncr.21822.CrossRefPubMed Zeliadt SB, Ramsey SD, Penson DF, Hall IJ, Ekwueme DU, Stroud L, Lee JW: Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006, 106 (9): 1865-1874. 10.1002/cncr.21822.CrossRefPubMed
11.
go back to reference Swords K, Wallen EM, Pruthi RS: The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach. Urol Oncol. 2010, 28 (3): 280-284. 10.1016/j.urolonc.2008.09.021.CrossRefPubMed Swords K, Wallen EM, Pruthi RS: The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach. Urol Oncol. 2010, 28 (3): 280-284. 10.1016/j.urolonc.2008.09.021.CrossRefPubMed
12.
go back to reference Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL: Men’s perspectives on selecting their prostate cancer treatment. J Natl Med Assoc. 2011, 103 (6): 468-478.CrossRefPubMedPubMedCentral Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL: Men’s perspectives on selecting their prostate cancer treatment. J Natl Med Assoc. 2011, 103 (6): 468-478.CrossRefPubMedPubMedCentral
13.
go back to reference Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS, Wein AJ, Malkowicz SB: Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?. Urology. 2009, 73 (3): 620-623. 10.1016/j.urology.2008.09.035.CrossRefPubMed Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS, Wein AJ, Malkowicz SB: Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?. Urology. 2009, 73 (3): 620-623. 10.1016/j.urology.2008.09.035.CrossRefPubMed
14.
go back to reference Bianco FJ, Wood DP, Grignon DJ, Sakr WA, Pontes JE, Powell IJ: Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. J Urol. 2002, 168 (2): 479-482. 10.1016/S0022-5347(05)64662-9.CrossRefPubMed Bianco FJ, Wood DP, Grignon DJ, Sakr WA, Pontes JE, Powell IJ: Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. J Urol. 2002, 168 (2): 479-482. 10.1016/S0022-5347(05)64662-9.CrossRefPubMed
15.
go back to reference Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA: African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer. 2006, 107 (1): 75-82. 10.1002/cncr.21954.CrossRefPubMed Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA: African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer. 2006, 107 (1): 75-82. 10.1002/cncr.21954.CrossRefPubMed
16.
go back to reference Moul JW, Connelly RR, Mooneyhan RM, Zhang W, Sesterhenn IA, Mostofi FK, McLeod DG: Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol. 1999, 162 (2): 394-397. 10.1016/S0022-5347(05)68568-0.CrossRefPubMed Moul JW, Connelly RR, Mooneyhan RM, Zhang W, Sesterhenn IA, Mostofi FK, McLeod DG: Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol. 1999, 162 (2): 394-397. 10.1016/S0022-5347(05)68568-0.CrossRefPubMed
17.
go back to reference Powell IJ, Bock CH, Ruterbusch JJ, Sakr W: Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010, 183 (5): 1792-1796. 10.1016/j.juro.2010.01.015.CrossRefPubMed Powell IJ, Bock CH, Ruterbusch JJ, Sakr W: Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010, 183 (5): 1792-1796. 10.1016/j.juro.2010.01.015.CrossRefPubMed
18.
go back to reference Song C, Kang T, Yoo S, Jeong IG, Ro JY, Hong JH, Kim CS, Ahn H: Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer. Urol Oncol. 2013, 31 (2): 168-174. 10.1016/j.urolonc.2010.11.005.CrossRefPubMed Song C, Kang T, Yoo S, Jeong IG, Ro JY, Hong JH, Kim CS, Ahn H: Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer. Urol Oncol. 2013, 31 (2): 168-174. 10.1016/j.urolonc.2010.11.005.CrossRefPubMed
19.
go back to reference Ward EM, Fedewa SA, Cokkinides V, Virgo K: The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J. 2010, 16 (6): 614-621. 10.1097/PPO.0b013e3181ff2aec.CrossRefPubMed Ward EM, Fedewa SA, Cokkinides V, Virgo K: The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J. 2010, 16 (6): 614-621. 10.1097/PPO.0b013e3181ff2aec.CrossRefPubMed
20.
go back to reference Carpenter WR, Howard DL, Taylor YJ, Ross LE, Wobker SE, Godley PA: Racial differences in PSA screening interval and stage at diagnosis. Cancer causes & control : CCC. 2010, 21 (7): 1071-1080. 10.1007/s10552-010-9535-4.CrossRefPubMedPubMedCentral Carpenter WR, Howard DL, Taylor YJ, Ross LE, Wobker SE, Godley PA: Racial differences in PSA screening interval and stage at diagnosis. Cancer causes & control : CCC. 2010, 21 (7): 1071-1080. 10.1007/s10552-010-9535-4.CrossRefPubMedPubMedCentral
21.
go back to reference Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW: Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis. 2009, 12 (3): 259-263. 10.1038/pcan.2009.11.CrossRefPubMed Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW: Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis. 2009, 12 (3): 259-263. 10.1038/pcan.2009.11.CrossRefPubMed
22.
go back to reference Jani AB, Vaida F, Hanks G, Asbell S, Sartor O, Moul JW, Roach M, Brachman D, Kalokhe U, Muller-Runkel R, Ray P, Ignacio L, Awan A, Weichselbaum RR, Vijayakumar S: Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int J Cancer. 2001, 96 (6): 363-371. 10.1002/ijc.1035.CrossRefPubMed Jani AB, Vaida F, Hanks G, Asbell S, Sartor O, Moul JW, Roach M, Brachman D, Kalokhe U, Muller-Runkel R, Ray P, Ignacio L, Awan A, Weichselbaum RR, Vijayakumar S: Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int J Cancer. 2001, 96 (6): 363-371. 10.1002/ijc.1035.CrossRefPubMed
23.
go back to reference Brawley OW: Prostate cancer epidemiology in the United States. World J Urol. 2012, 30 (2): 195-200. 10.1007/s00345-012-0824-2.CrossRefPubMed Brawley OW: Prostate cancer epidemiology in the United States. World J Urol. 2012, 30 (2): 195-200. 10.1007/s00345-012-0824-2.CrossRefPubMed
24.
go back to reference Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H, Curnen MG, Dubrow R: Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2825-2834. 10.1158/1055-9965.EPI-08-0203.CrossRefPubMed Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Soler-Vila H, Curnen MG, Dubrow R: Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2825-2834. 10.1158/1055-9965.EPI-08-0203.CrossRefPubMed
25.
go back to reference Underwood W, Wei J, Rubin MA, Montie JE, Resh J, Sanda MG: Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol. 2004, 22 (1): 20-24. 10.1016/S1078-1439(03)00119-4.CrossRefPubMed Underwood W, Wei J, Rubin MA, Montie JE, Resh J, Sanda MG: Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol. 2004, 22 (1): 20-24. 10.1016/S1078-1439(03)00119-4.CrossRefPubMed
26.
go back to reference Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT: Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004, 171 (4): 1504-1507. 10.1097/01.ju.0000118907.64125.e0.CrossRefPubMed Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT: Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004, 171 (4): 1504-1507. 10.1097/01.ju.0000118907.64125.e0.CrossRefPubMed
27.
go back to reference Wood HM, Reuther AM, Gilligan TD, Kupelian PA, Modlin CS, Klein EA: Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration. J Urol. 2007, 178 (4 Pt 1): 1271-1276.CrossRefPubMed Wood HM, Reuther AM, Gilligan TD, Kupelian PA, Modlin CS, Klein EA: Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration. J Urol. 2007, 178 (4 Pt 1): 1271-1276.CrossRefPubMed
28.
go back to reference Powell IJ, Banerjee M, Novallo M, Sakr W, Grignon D, Wood DP, Pontes JE: Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 2000, 55 (2): 246-251. 10.1016/S0090-4295(99)00436-7.CrossRefPubMed Powell IJ, Banerjee M, Novallo M, Sakr W, Grignon D, Wood DP, Pontes JE: Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 2000, 55 (2): 246-251. 10.1016/S0090-4295(99)00436-7.CrossRefPubMed
29.
go back to reference Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, et al: Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 2011, 43 (6): 570-573. 10.1038/ng.839.CrossRefPubMedPubMedCentral Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, et al: Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 2011, 43 (6): 570-573. 10.1038/ng.839.CrossRefPubMedPubMedCentral
30.
go back to reference Baffoe-Bonnie AB, Kittles RA, Gillanders E, Ou L, George A, Robbins C, Ahaghotu C, Bennett J, Boykin W, Hoke G, Mason T, Pettaway C, Vijayakumar S, Weinrich S, Jones MP, Gildea D, Riedesel E, Albertus J, Moses T, Lockwood E, Klaric M, Faruque M, Royal C, Trent JM, Berg K, Collins FS, Furbert-Harris PM, Bailey-Wilson JE, Dunston GM, Powell I, et al: Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC). Prostate. 2007, 67 (1): 22-31. 10.1002/pros.20456.CrossRefPubMed Baffoe-Bonnie AB, Kittles RA, Gillanders E, Ou L, George A, Robbins C, Ahaghotu C, Bennett J, Boykin W, Hoke G, Mason T, Pettaway C, Vijayakumar S, Weinrich S, Jones MP, Gildea D, Riedesel E, Albertus J, Moses T, Lockwood E, Klaric M, Faruque M, Royal C, Trent JM, Berg K, Collins FS, Furbert-Harris PM, Bailey-Wilson JE, Dunston GM, Powell I, et al: Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC). Prostate. 2007, 67 (1): 22-31. 10.1002/pros.20456.CrossRefPubMed
Metadata
Title
Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy
Authors
Kelvin A Moses
Ling Y Chen
Daniel D Sjoberg
Melanie Bernstein
Karim A Touijer
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2014
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/1471-2490-14-98

Other articles of this Issue 1/2014

BMC Urology 1/2014 Go to the issue